Q'Apel Medical Welcomes Stewart Strong as New CEO

Author: Evelyn Baker Updated: 07-01-2025 08:12 AM

Stewart Strong Takes the Helm at Q'Apel Medical

In a significant move, Q'Apel Medical has appointed Stewart Strong as its new President and Chief Executive Officer. With a wealth of expertise and a commitment to innovation, Strong is expected to guide the company in its next phase of growth.

Stewart's Vision for Q'Apel

In his new role, Stewart Strong aims to expand Q'Apel's market presence while ensuring that the company continues to provide clinical value to both physicians and patients. His focus will be on advancing the pipeline of innovations that Q'Apel is known for.

A Proven Leader

Strong is recognized as an innovation-focused leader with an impressive track record in the medical device sector. His extensive experience has positioned him to effectively lead high-performing global teams and develop commercial strategies that drive growth.

Experience That Matters

Before joining Q'Apel, Stewart Strong served as the Global President of the Hospital Business Unit at Haemonetics, where he significantly increased revenue and established a thriving global commercial organization. His experience extends across multiple roles, providing him a solid foundation for his leadership at Q'Apel.

Endorsements from Leadership

R. King Nelson, Q'Apel's Chairman of the Board, spoke highly of Strong's appointment. He expressed confidence that Strong is the right person to lead Q'Apel into a promising future, highlighting his passion for building effective teams and driving sustainable growth.

Strong's Commitment to Q'Apel's Mission

Stewart Strong emphasized his excitement about joining Q'Apel, a leader in the neurovascular space. He is eager to work with the Board of Directors and executive leadership team to advance the company’s mission and harness its full potential.

About Q'Apel Medical

Q'Apel Medical is dedicated to revolutionizing neurovascular interventions. Their customer-centric approach addresses clinical challenges that often go unmet. The team at Q'Apel is passionate about delivering high-quality, uniquely engineered products designed through collaboration with neurovascular specialists.

As an innovative force, Q'Apel Medical is committed to staying at the forefront of this essential field. Their focus on creating solutions for current and future medical needs underscores their dedication to enhancing patient care.

Media Contact Information

For media inquiries, please contact:

Charlene Herndon
SPRIG Consulting

Frequently Asked Questions

Who is Stewart Strong?

Stewart Strong is the new President and Chief Executive Officer of Q'Apel Medical, bringing over 25 years of experience in the medical device industry.

What is Q'Apel Medical known for?

Q'Apel Medical is focused on revolutionizing neurovascular interventions with innovative products designed to address current clinical challenges.

What experience does Stewart Strong have?

Prior to joining Q'Apel, Stewart was the Global President of Haemonetics' Hospital Business Unit and has held executive roles in major medical companies.

What are Stewart Strong's priorities at Q'Apel?

His primary goals include expanding the company's market presence, delivering clinical value, and advancing the innovation pipeline.

How can one learn more about Q'Apel Medical?

For more information about Q'Apel Medical, please visit their official website.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.